Filing Flows › CervoMed (CRVO) › R&D spending
CervoMed (CRVO) R&D spending by quarter
CervoMed's R&D spending was $5.8M in Q4 2025 (fourth quarter 2025), -3% from Q3 2025. Over the last 5 quarters it ranged from $4.8M (Q1 2025) to $7.1M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $5.8M | -3% | -18% |
| Q3 2025 | $6.0M | +18% | — |
| Q2 2025 | $5.1M | +6% | — |
| Q1 2025 | $4.8M | -32% | — |
| Q4 2024 | $7.1M | — | — |
Q4 2025 at a glance
CervoMed, Q4 2025: revenue $9K (-100% year over year), net loss $8.1M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is CervoMed's R&D spending?
CervoMed's R&D spending was $5.8M in Q4 2025 (fourth quarter 2025), -3% from Q3 2025.
How has CervoMed's R&D spending changed?
Over the last 5 quarters it ranged from $4.8M (Q1 2025) to $7.1M (Q4 2024).